Discover 2,450 paid clinical trials in North Carolina. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
From paid studies for healthy volunteers to condition-specific trials, North Carolina offers a wide range of clinical research opportunities. Leading medical centers in Charlotte, Raleigh, and Durham are seeking participants, providing access to innovative treatments and comprehensive care.
Filter
1
Filter results
Results: 2,450
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
for
Ovarian Cancer
Location: Boston MA, New York NY, Paramus NJ, Bethlehem PA,
Sponsor: Daiichi Sankyo
Sex: Female
Age: 18+
Code: NCT06819007
Phase3, Recruiting
Open-Label, Dose-Escalation With Expansion to Assess the Safety, Tolerability, and PK of TRE-515 in Subjects With Solid Tumors
for
Solid Tumor, Adult, Oncology
Location: Huntersville NC, Santa Monica CA
Sponsor: Trethera
Sex: All
Age: 18+
Code: NCT05055609
Phase1, Recruiting
Vibration and Post-traumatic Osteoarthritis Risk Following ACL Injury
Sponsor: University of North Carolina, Chapel Hill
Sex: All
Age: 16 - 35
Code: NCT04875052
Recruiting
A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma
for
Plasma Cell Myeloma Refractory
Location: Boston MA, New Haven CT, New York NY, Hackensack NJ,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT06356571
Phase2, Recruiting
Prospective Measurement of Normal Venous Sinus Pressures
for
Intracranial Venous Pressures
Location: Winston-Salem NC
Sponsor: Wake Forest University Health Sciences
Sex: All
Age: 18 - 60
Code: NCT03948971
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
for
Acute Respiratory Distress Syndrome (ARDS), ARDS,
Location: Burlington MA, The Bronx NY, New Brunswick NJ,
Sponsor: PPD Development, LP
Sex: All
Age: 18+
Code: NCT06701656
Phase2, Recruiting
Discharge Readmission Analysis and Management in Sepsis (DReAMS-2)
for
Sepsis
Location: Raleigh NC, Durham NC
Sponsor: Measure Labs, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06099756
Recruiting
A Phase 1/1b Study of IAM1363 in HER2 Cancers
for
HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer,
Location: Boston MA, Lebanon NH, New York NY, New Brunswick NJ,
Sponsor: Iambic Therapeutics, Inc
Sex: All
Age: 18+
Code: NCT06253871
Phase1, Recruiting
Virtual Reality Mindfulness Meditation After ACL Reconstruction
for
Anterior Cruciate Ligament Injury
Location: Chapel Hill NC
Sponsor: University of North Carolina, Chapel Hill
Sex: Female
Age: 14 - 25
Code: NCT05527171
Recruiting
A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
for
Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis,
Location: Boston MA, Durham NC, Chapel Hill NC, South Miami FL,
Sponsor: UCB Biopharma SRL
Sex: Female
Age: 18+
Code: NCT06888193
Phase1, Recruiting
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
for
Metastatic Uveal Melanoma, Cutaneous Melanoma,
Location: Philadelphia PA, Durham NC, Cincinnati OH, Nashville TN,
Sponsor: IDEAYA Biosciences
Sex: All
Age: 18+
Code: NCT03947385
Phase1, Phase2, Recruiting
ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer
Sponsor: UNC Lineberger Comprehensive Cancer Center
Sex: Female
Age: 18+
Code: NCT05542407
Phase1, Recruiting
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
for
Type 1 Diabetes Mellitus With Hypoglycemia
Location: New Haven CT, Long Island City NY, New York NY,
Sponsor: Zucara Therapeutics Inc.
Sex: All
Age: 18 - 70+
Code: NCT05762107
Phase2, Recruiting
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
for
Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen,
Location: Boston MA, New Haven CT, New York NY, Montreal,
Sponsor: Servier Bio-Innovation LLC
Sex: All
Age: 18+
Code: NCT06127407
Phase3, Recruiting
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
for
Hodgkin Lymphoma in Remission, Leukemia in Remission,
Location: Scarborough ME, Boston MA, Providence RI, New Haven CT,
Sponsor: Children's Oncology Group
Sex: All
Age: 0+
Code: NCT01790152
Recruiting
Clinical Study of ARD103 CAR-T Therapy for Patients With R/R AML or MDS
for
Acute Myeloid Leukemia, in Relapse,
Location: Winston-Salem NC, Charlotte NC, Houston TX
Sponsor: ARCE Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06680752
Phase1, Phase2, Recruiting
PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)
for
Hematologic Malignancies,
Location: Boston MA, Hackensack NJ, Baltimore MD, Chapel Hill NC,
Sponsor: Pulmotect, Inc.
Sex: All
Age: 18+
Code: NCT06665100
Phase2, Recruiting
Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
for
Idiopathic Pulmonary Fibrosis
Location: Farmington CT, New York NY, Philadelphia PA,
Sponsor: Cumberland Pharmaceuticals
Sex: All
Age: 40+
Code: NCT05571059
Phase2, Recruiting
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
for
Solid Tumors
Location: Boston MA, New Haven CT, New York NY, Philadelphia PA,
Sponsor: ORIC Pharmaceuticals
Sex: All
Age: 18+
Code: NCT05315700
Phase1, Phase2, Recruiting
USCRI READY4Life Program
for
Communication, Problem Solving, Social Relationships,
Location: Colchester VT, Philadelphia PA, Raleigh NC, Miami FL,